Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 USD | -4.68% | -12.84% | +187.15% |
04-18 | JonesTrading Starts Rezolute With Buy Rating, $10 Price Target | MT |
03-06 | Rezolute, Inc. Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+187.15% | 114M | |
+5.66% | 111B | |
+11.23% | 105B | |
-0.38% | 21.93B | |
-12.15% | 22.34B | |
-7.66% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- RZLT Stock
- News Rezolute, Inc.
- Canaccord Genuity Adjusts Price Target on Rezolute to $17 From $30, Maintains Buy Rating